Brian M. Goldberg


Brian M. Goldberg


Philadelphia | Cira Centre, 2929 Arch Street, Philadelphia, PA, United States of America 19104-2808
+1 215 994 2143 | +1 215 994 2222


Brian M. Goldberg focuses his practice on intellectual property with an emphasis on patent litigation and particular focus on life sciences. In addition to his intellectual-property work, Mr. Goldberg maintains an active pro bono practice in a variety of areas.

Mr. Goldberg has extensive experience litigating Hatch-Waxman Act ANDA infringement actions, and has actively participated in all phases of litigation from drafting complaints, preparing infringement contentions, managing discovery, preparing for and defending depositions, assisting in Markman briefing and hearings, working with infringement and validity experts, drafting motions, preparing pretrial filings, participating in trial teams, and assisting with appeals. Since joining Dechert, Mr. Goldberg has played an integral role in litigation teams for a significant number of patent litigations in federal courts throughout the United States for various branded pharmaceutical companies including Endo Pharmaceuticals and Baxter.

Prior to joining Dechert, Mr. Goldberg was an associate at a large law firm where he gained valuable experience in general litigation, intellectual property and patent litigation including the representation of multinational manufactures of generic pharmaceuticals in Hatch-Waxman Act ANDA infringement actions.

  • Endo Pharmaceuticals v. Teva, et al. (U.S. District Court, Southern District of New York). Trial counsel for Endo Pharmaceuticals in Hatch-Waxman Act case filed against a dozen ANDA filers involving Endo's OPANA® ER product. Following a five-week trial, the court ruled in Endo's favor, finding its patents valid and infringed. Dechert later secured Federal Circuit affirmance of its hard-fought patent trial victory while the case was on appeal, enjoining all generics through 2023.
  • Member of litigation team representing multinational manufacturers of generic pharmaceuticals in Hatch-Waxman patent litigation and appeals.
  • Member of litigation team representing seller of a midtown Manhattan office building prosecuting claims for breach of Purchase and Sale Agreement by ostensible purchaser, winning a motion for summary judgment allowing seller to retain a US $38.5 million deposit on the sale, plus interest.
  • Member of trial team representing a large financial institution in an eight-day bench trial in the Southern District of New York. After a defense verdict for the financial institution at trial the case settled favorably on appeal. 

Includes matters handled at Dechert or prior to joining the firm.

  • University of Pennsylvania, B.A., Biological Basis of Behavior, 2008
  • Fordham University School of Law, J.D., 2011, Ruth Whitehead Daly Scholar; Associate Editor, Fordham Intellectual Property, Media and Entertainment Law Journal
  • New Jersey
  • New York
  • Pennsylvania
  • United States District Court for the District of New Jersey
  • United States District Court for the Eastern District of New York
  • United States District Court for the Southern District of New York